Did you know?

2001: The FDA approves Gleevec®, a drug developed by LLS-funded researcher Brian Druker, M.D., to treat patients with CML and other blood cancers.

FDA approves Kyprolis for some patients with multiple myeloma

The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including treatment with Velcade (bortezomib) and an immunomodulatory therapy. Read more.
last updated on Friday, July 20, 2012
btn_sharethis

E-Newsletters


Sign Up For Free
Subscribe to one of LLS's Monthly eNewsletters
Your Name

Your Email

Your Zip Code


About E-News»